Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements

BSE: 532908Pharmaceuticals & Biotechnology

Last traded ₹3.30 on 28 Mar 2019

Delisted on 20 Feb 2024.

Sharon Bio-Medicine Ltd-$ share news and announcements

831 announcements, routine notices left out, newest first. Page 6 of 17.

Jul 2019
- 4 Jul · Related Party Transactions
  Submission of disclosure on Related Party Transactions. (opens in a new tab)
- 4 Jul · Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2019
  Disclosure of Related Party Transactions of the Company on .... (opens in a new tab)
Jun 2019
- 12 Jun · Legal
  Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. (opens in a new tab)
May 2019
- 30 May · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
- 27 May · Updates
  Copy of advertisement published in newspaper (opens in a new tab)
- 24 May · Board meeting
  Financial Results for the year ended March 31, 2019 (opens in a new tab)
- 24 May · Board meeting
  Board meeting held on May 24, 2019. (opens in a new tab)
- 24 May · Results
  Following documents are enclosed: Audited financial results for the quarter .... (opens in a new tab)
- 24 May · Results
  Financial results for the period ended March 31, 2019. (opens in a new tab)
- 21 May · Disclosure
  Annual Disclosure under Regulation 30(1) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019. (opens in a new tab)
- 15 May · Updates
  Intimation for consideration and declaration of Audited financial results for the year ended March 31, 2019. (opens in a new tab)
- 10 May · Board meeting
  SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2019 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
- 10 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019 (opens in a new tab)
- 2 May · Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
  Dear Sir/Madam, With reference to the above referred subject, we are enclosing herewith the Confirmation Certificate dated April 16, 20 19 received from M/s. Link Intime India .... (opens in a new tab)
- 2 May · Updates
  Certificate under Regulation 74 (5) of Securities and Exchange Board of India(Depositories and Participants) Regulations 2018 (opens in a new tab)
Apr 2019
- 25 Apr · Certificate Under Regulation 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2019
  Please find enclosed, Certificate dated April 22, 2019, issued by M/s. Kotak & Associates, Practicing Company Secretary pursuant to Regulation 40(9) of the Securities and Exchange Board .... (opens in a new tab)
- 25 Apr · Compliance Certificate - Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Dear Sir/Madam, As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in .... (opens in a new tab)
- 17 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 16 Apr · Shareholding for the Period Ended March 31, 2019
  Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....
Mar 2019
- 25 Mar · Suspension of Trading
  Members of the Exchange are hereby informed that the trading in Equity Shares of Sharon Bio-Medicine Limited shall be suspended w.e.f. March 29, 2019 (i.e. closing hours of trading on March 28, 2019) on account of Reduction of Share Capital
- 19 Mar · Corporate action
  Company has fixed Record Date as April 2, 2019 for the purpose of Reduction of Equity Share Capital of the Company pursuant to theResolution Plan approved by the Hon'ble National Company Law Tribunal (opens in a new tab)
- 18 Mar · Corporate action
  We hereby inform you that pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant provisions .... (opens in a new tab)
- 12 Mar · Updates
  Withdrawal of Closure Notice for the manufacturing activity of API Plant (opens in a new tab)
- 12 Mar · Withdrawal Of Closure Notice For The Manufacturing Activity Of API Plant
  As per Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 and Schedule III Part A, we hereby disclose that Maharashtra Pollution Control Board (MPCB) .... (opens in a new tab)
Feb 2019
- 22 Feb · Updates
  Update on USFDA inspection at our API facility. (opens in a new tab)
- 22 Feb · Update On USFDA Inspection At Our API Facility
  As per Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 and Schedule III Part A, we hereby disclose that the company's API facility located at L-6, .... (opens in a new tab)
- 20 Feb · Updates
  Recovery notice from the Commissioner of State Tax for the year 2011-12 and 2015-16 (opens in a new tab)
- 20 Feb · Business
  As per Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, we hereby disclose that the Company has received Recovery Notice under sub-section (1) of Section .... (opens in a new tab)
- 14 Feb · Results
  Dear Sir/Madam, Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirement) Regulations, 2015, please find enclosed herewith Standalone Unaudited Financial Results .... (opens in a new tab)
- 14 Feb · Results
  Financial results for the period ended December 31, 2018. (opens in a new tab)
- 7 Feb · Legal
  Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 28-Jan-2019, regarding 'Closure of operations of API plant '.". On basis of above the Company is required to clarify following: 1. Date of closure or estimated time of closure;2. Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year;The response of the Company is attached. (opens in a new tab)
- 6 Feb · Board meeting
  Notice to consider and approve Unaudited Financial Results for the Quarter ended December 31, 2018.Pursuant to Regulation 29(1) (a) of the SEBI (Listing obligations and disclosure requirements) Regulations 2015, Unaudited Financial Results of the Company will be considered and approved for the quarter ended December 31, 2018 on Thursday, February 14, 2019 at the corporate office of the Company at 601, Proxima, Plot No. 19, Sector-30(A), Vashi, Navi Mumbai - 400705 at 3:00 P.M. (opens in a new tab)
- 6 Feb · Board meeting
  SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve In connection with the .... (opens in a new tab)
- 1 Feb · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 28-Jan-2019, regarding 'Closure of operations of API plant '.". On basis of above the Company is required to clarify following: 1. Date of closure or estimated time of closure;2. Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year;The response of the Company is awaited.
Jan 2019
- 29 Jan · Legal
  Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 09-Jan-2019, regarding that Ms. Komal Mota has been appointed as a Company Secretary & Compliance Officer w.e.f January 08, 2019." On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)The response of the Company is enclosed.Ms. Komal Mota is a qualified Company Secretary and LLB having more than 4 years of experience and worked with Listed and Private Companies.
- 28 Jan · Updates
  Closure of operations of API plant (opens in a new tab)
- 28 Jan · Closure Of Operations Of API Plant
  As per Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 and Schedule III Part A, we hereby disclose that API plant located at L-6, MIDC, Taloja, Dist. .... (opens in a new tab)
- 17 Jan · Shareholding for the Period Ended December 31, 2018
  Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....
- 16 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 11 Jan · Legal
  Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to announcement dated 09-Jan-2019, regarding that Ms. Komal Mota has been appointed as a Company Secretary & Compliance Officer w.e.f January 08, 2019." On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)The response of the Company is awaited.
- 9 Jan · Change in Company Secretary/Compliance Officer
  Ms. Komal Mota has been appointed as a Company Secretary & Compliance Officer w.e.f January 08, 2019. (opens in a new tab)
- 9 Jan · Intimation With Regard To Regulation 30(A)(Schedule III) Of SEBI (LODR) Regulations, 2015
  This is to inform that Ms. Komal Mota has been appointed as a Company Secretary & Compliance Officer w.e.f 8th January, 2019 (opens in a new tab)
Dec 2018
Nov 2018